(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium

Por Jiménez-Díaz, María Belén, Ebert, Daniel, Salinas, Yandira, Pradhan, Anupam, Lehane, Adele M., Myrand-Lapierre, Marie-Eve, O’Loughlin, Kathleen G., Shackleford, David M., Justino de Almeida, Mariana, Carrillo, Angela K., Clark, Julie A., Dennis, Adelaide S. M., Diep, Jonathon, Deng, Xiaoyan, Duffy, Sandra, Endsley, Aaron N., Fedewa, Greg, Guiguemde, W. Armand, Gómez, María G., Holbrook, Gloria, Horst, Jeremy, Kim, Charles C., Liu, Jian, Lee, Marcus C. S., Matheny, Amy, Martínez, María Santos, Miller, Gregory, Rodríguez-Alejandre, Ane, Sanz, Laura, Sigal, Martina, Spillman, Natalie J., Stein, Philip D., Wang, Zheng, Zhu, Fangyi, Waterson, David, Knapp, Spencer, Shelat, Anang, Avery, Vicky M., Fidock, David A., Gamo, Francisco-Javier, Charman, Susan A., Mirsalis, Jon C., Ma, Hongshen, Ferrer, Santiago, Kirk, Kiaran, Angulo-Barturen, Iñigo, Kyle, Dennis E., DeRisi, Joseph L., Floyd, David M., Guy, R. Kiplin
Publicado no Proc Natl Acad Sci U S A (2014)